Skip to main content
. 2022 Dec 7;12:939819. doi: 10.3389/fonc.2022.939819

Figure 1.

Figure 1

One-year cumulative incidence of relapse. (A) according to ASXL1 mutation; (B) according to TP53 mutation; (C) according to WT1 mutation; (D) according to NRAS mutation; (E) according to FLT3 mutation; (F) according to cytogenetic risk; (G) according to ELN risk; (H) according to remission status at transplant.